MB Diagnostics ApS: Financial statements 2019
CVR: 38185853
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
MB Diagnostics ApS (CVR 38185853) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 585,836 and a net result of DKK 447,892 compared with DKK 491,251 the year before. That is a decrease of 9.1% compared with the year before. Equity in the 2019 report amounted to DKK 826,557. The solvency ratio was 63.8%.
- Gross Profit
- DKK 585,836
- Profit/Loss
- DKK 447,892
- Equity
- DKK 826,557
- Total Assets
- DKK 1,295,633
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 586 t. | 448 t. | 827 t. | 0 |
| 2018 | - | 645 t. | 491 t. | 379 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
MB Diagnostics ApS has published its annual report for 2018. Gross profit came to DKK 644,667, and the net result was DKK 491,251.
About MB Diagnostics ApS
MB Diagnostics ApS is a Danish company of the type Anpartsselskab based in Nærum, founded in 2016. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The management consists of Mikael Ploug Boesen. The company is owned by Mikael Ploug Boesen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,000 and a net result of DKK -23,026 compared with DKK -15,293 the year before. Equity in the 2025 report amounted to DKK 566,629.